Boesen Biotech ApS: Financial statements 2019
CVR: 39142635
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Boesen Biotech ApS (CVR 39142635) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -13,607 and a net result of DKK -1,803 compared with DKK -535,708 the year before. Equity in the 2019 report amounted to DKK -226,874.
- Gross Profit
- DKK -13,607
- Profit/Loss
- DKK -1,803
- Equity
- DKK -226,874
- Total Assets
- DKK 3,732,618
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -14 t. | -2 t. | -227 t. | - |
| 2018 | - | -20 t. | -536 t. | -225 t. | - |
| 2017 | - | -19 t. | 261 t. | 311 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Boesen Biotech ApS has published its annual report for 2018. Gross profit came to DKK -20,020, and the net result was DKK -535,708.
About Boesen Biotech ApS
Boesen Biotech ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Thomas Boesen. The company is owned by T. BOESEN HOLDING ApS and Gudter ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -54,998 and a net result of DKK 2,039,886 compared with DKK 723,812 the year before. Equity in the 2025 report amounted to DKK 3,496,600.